Document is current
Any future updates will be listed below
-
Authors
Yu, Jieqing
Ding, Le
Yang, Yong
Xie, Tao
Peng, Junbo
Luo, Qing
Huang, Xuan
Li, Yong https://orcid.org/0000-0002-4108-0989
Ye, Jing
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (32170793)
National Natural Science Foundation of China (82560587)
National Natural Science Foundation of China (32560166)
Natural Science Foundation of Jiangxi Province (20224ACB216013)
Natural Science Foundation of Jiangxi Province (20242BAB25492)
Jiangxi Provincial Key Laboratory of Bioengineering Drugs (2024SSY07061)
Central Funds Guiding the Local Science and Technology Development (20221ZDG020066)
- License Information
-
More Information
Article History
Received: 29 October 2025
Revised: 18 May 2026
Accepted: 20 May 2026
First Online: 6 June 2026
Declarations
Competing interests: The authors declare no competing interests.
Ethics approval: Clinical NPC samples were obtained from the Department of Pathology at the First Affiliated Hospital of Nanchang University, Nanchang, China. The use of these clinical samples was reviewed and approved by the Medical Research Ethics Committee of the Affiliated Hospital of Nanchang University (Approval No. (2023)CDYFYYLK(07–013)). Informed consent was obtained from all patients prior to the use of their tissue samples. All animal experiments were approved by The Institutional Animal Care and Use Committee of The First Affiliated Hospital of Nanchang University (Approval No.: CDYFY-IACUC-202307QR010) and conducted in compliance with the ARRIVE guidelines. All methods were carried out in accordance with relevant guidelines and regulations.
